In today's edition of Market Checkup, health-care analysts David Williamson and Max Macaluso take a close look at Johnson & Johnson, the largest health-care company in the Dow. They discuss the key takeaways from Johnson & Johnson's second-quarter results and look at its main opportunities in the medical device, pharmaceutical, and consumer health-care spaces.
- Aug 13, 2013 at 6:28PM
- Health Care
- This Is Exactly How Much Money Experts Say You Should Stash in an Emergency Fund
- Coke Zero Sugar and Pricing Strength Are Driving Coca-Cola's Results
- Strong Cash Flows Allow Steel Dynamics to Continue Expanding
- After Two Years, a Chipotle Bear Changes His Tune Just Before Earnings
- IBM's Weak Results Hide Its Growth Potential